These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19702451)

  • 1. Heart failure in women: epidemiology, biology and treatment.
    Shah RU; Klein L; Lloyd-Jones DM
    Womens Health (Lond); 2009 Sep; 5(5):517-27. PubMed ID: 19702451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveat anicula! Beware of quiet little old ladies: demographic features, pharmacotherapy, readmissions and survival in a 10-year cohort of patients with heart failure and preserved systolic function.
    Wong DT; Clark RA; Dundon BK; Philpott A; Molaee P; Shakib S
    Med J Aust; 2010 Jan; 192(1):9-13. PubMed ID: 20047541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure in women.
    Silber DH
    Curr Womens Health Rep; 2003 Apr; 3(2):104-9. PubMed ID: 12628079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic management of heart failure with preserved ejection fraction.
    Huang D; Cheng JW
    Ann Pharmacother; 2010 Dec; 44(12):1933-45. PubMed ID: 21098754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in diastolic heart failure: an update.
    Fitzgibbons TP; Meyer TE; Aurigemma GP
    Cardiol Rev; 2009; 17(2):51-5. PubMed ID: 19367145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-related differences in heart failure and beta-blockers.
    Ghali JK
    Heart Fail Rev; 2004 Apr; 9(2):149-59. PubMed ID: 15516863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The less familiar side of heart failure: symptomatic diastolic dysfunction.
    Morris SA; Van Swol M; Udani B
    J Fam Pract; 2005 Jun; 54(6):501-11. PubMed ID: 15939000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S; Opasich C
    Ital Heart J; 2003 Aug; 4(8):511-3. PubMed ID: 14564974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic heart failure: state of the science on best treatment practices.
    Reddersen LA; Keen C; Nasir L; Berry D
    J Am Acad Nurse Pract; 2008 Oct; 20(10):506-14. PubMed ID: 19128346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure.
    Freeman JV; Yang J; Sung SH; Hlatky MA; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):525-33. PubMed ID: 24021697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Response to drug therapy of cardiac failure according to gender].
    Juillière Y; Berder V; Brembilla-Perrot B; Selton-Suty C
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1216-20. PubMed ID: 15669363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.
    Gjesing A; Schou M; Torp-Pedersen C; Køber L; Gustafsson F; Hildebrandt P; Videbæk L; Wiggers H; Demant M; Charlot M; Gislason GH
    Eur J Heart Fail; 2013 Jun; 15(6):671-8. PubMed ID: 23397577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diastolic heart failure: are problems in its diagnosis and treatment solvable?].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2009; 81(11):73-6. PubMed ID: 20141020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment for chronic systolic heart failure.
    Mörike K; Sindermann JR
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.